Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

203.50p
   
  • Change Today:
      1.00p
  • 52 Week High: 206.33p
  • 52 Week Low: 126.38p
  • Currency: UK Pounds
  • Shares Issued: 85.23m
  • Volume: 575,986
  • Market Cap: £173.45m
  • RiskGrade: 196

Diaceutics Overview

Diaceutics is a data analytics and implementation services company which services the global pharmaceutical industry. It has established a suite of data-driven products and implementation services powered by the data held in its proprietary database. Its products and services are focused on optimising its clients’ strategies for the development and launch of precision medicines and specifically, the diagnostic testing required to guide selection of such medicines. The Group currently provides services to 20 of the 30 largest global pharmaceutical companies.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 0.1% n/a
ROCE 0.2%  
Latest F'cast
P/E 11.7 n/a
PEG n/a n/a
Pr/Revenue 2.9 n/a
Pr/Book 2.7  
Latest F'cast
Revenue 19.5% n/a
PBT -84.2% n/a
EPS n/a n/a
DPS n/a n/a

Diaceutics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 13.94 0.46 0.67p 152.2 n/a -10% n/a 0.0%
31-Dec-22 19.50 0.56 0.86p 87.8 3.1 +28% n/a 0.0%
31-Dec-23 23.70 (2.44) (2.07)p n/a n/a n/a n/a 0.0%
31-Dec-24 32.16 1.91 (202.00)p n/a n/a n/a n/a 0.0%
31-Dec-25 38.44 0.30 11.00p 11.6 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Diaceutics Company Announcements

Precision for All - Capital Markets Webinar 14-Oct-2026 07:00 RNS
Holding(s) in Company 12-Oct-2026 10:47 RNS
Holding(s) in Company 07-Oct-2026 07:10 RNS

Latest Diaceutics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 203.50p
Change Today 1.00p
% Change 0.49 %
52 Week High 206.33p
52 Week Low 126.38p
Volume 575,986
Shares Issued 85.23m
Market Cap £173.45m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46% below the market average46% below the market average46% below the market average46% below the market average46% below the market average
30.77% above the sector average30.77% above the sector average30.77% above the sector average30.77% above the sector average30.77% above the sector average
Price Trend
39.24% above the market average39.24% above the market average39.24% above the market average39.24% above the market average39.24% above the market average
86.21% above the sector average86.21% above the sector average86.21% above the sector average86.21% above the sector average86.21% above the sector average
Income Not Available
Growth
21.01% below the market average21.01% below the market average21.01% below the market average21.01% below the market average21.01% below the market average
57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average

Diaceutics Dividends

No dividends found

Trades for 16-Oct-2026

Time Volume / Share Price
12:10 100,000 @ 202.00p
16:41 150,000 @ 203.52p
16:04 5,500 @ 203.50p
16:03 1,000 @ 203.80p
16:00 10,000 @ 203.50p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page